Advertisement

Organisation › Details
Biognosys AG
At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery®, TrueTarget®, and TrueSignature® research service platforms, our flagship software Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible. *
![]() |
Start | 2008-09-09 splitoff |
Group | Bruker (Group) | |
Predecessor | ETH Zürich (ETHZ) | |
![]() |
Industry | proteomics |
Industry 2 | multiple reaction monitoring (MRM) technology | |
![]() |
Person | Rinner, Oliver (Biognosys 202109 CEO + Co-Founder) |
Person 2 | Novak, Lidia (Biognosys 2019089 CFO) | |
![]() |
Region | Schlieren ZH |
Country | Switzerland | |
Street | 21 Wagistr. | |
City | 8952 Schlieren ZH | |
Tel | +41-44-738-2040 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2022-01-01) |
* Document for »About Section«: Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Bruker (Group)
- [1] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [2] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [3] Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich....
- [4] Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne....
- [5] Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich....
- [6] Bruker Corporation. (8/23/24). "Press Release: Bruker Corporation to Present at Upcoming Investor Conferences". Billerica, MA....
- [7] Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix"....
- [8] Bruker Corporation. (7/2/24). "Press Release: Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin". Berlin....
- [9] Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen....
- [10] NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top